Epigenomic data is crucial for understanding cancer because epigenetic changes can contribute to the initiation and progression of cancer. These changes can activate oncogenes or silence tumor suppressor genes without altering the DNA sequence. By studying the epigenomic landscape of cancer cells, researchers can identify biomarkers for early detection, prognosis, and potential therapeutic targets.
